Carboxyhemoglobin formation as an unexpected side effect of inhaled nitric oxide therapy in severe acute respiratory distress syndrome
Détails
ID Serval
serval:BIB_A480F3E3973D
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Carboxyhemoglobin formation as an unexpected side effect of inhaled nitric oxide therapy in severe acute respiratory distress syndrome
Périodique
Critical Care Medicine
ISSN
0090-3493 (Print)
Statut éditorial
Publié
Date de publication
12/2004
Volume
32
Numéro
12
Pages
2537-9
Notes
Case Reports
Journal Article
Research Support, Non-U.S. Gov't --- Old month value: Dec
Journal Article
Research Support, Non-U.S. Gov't --- Old month value: Dec
Résumé
OBJECTIVE: To report an unexpected cause of carboxyhemoglobinemia associated with inhaled nitric oxide therapy in severe acute respiratory distress syndrome. DESIGN: Case report. SETTING: Medical critical care unit at Lausanne University Hospital. PATIENT: One female patient with acute respiratory distress syndrome treated with inhaled nitric oxide, who developed a simultaneous increase in blood methemoglobin and carboxyhemoglobin. CONCLUSIONS: Potential pathophysiologic mechanisms linking acute respiratory distress syndrome, inhaled nitric oxide, methemoglobin, and carboxyhemoglobin are discussed. Since carboxyhemoglobin has a negative influence on oxygen-carrying capacity, this effect may potentially offset the beneficial influence (if any) of inhaled nitric oxide on arterial PO2. This observation does not support the use of inhaled nitric oxide in the treatment of acute respiratory distress syndrome.
Mots-clé
Administration, Inhalation
Aged
Blood Chemical Analysis
Carboxyhemoglobin/drug effects/*metabolism
Critical Care/methods
Critical Illness
Disease Progression
Fatal Outcome
Female
Hematologic Diseases/chemically induced
Humans
Intensive Care Units
Methemoglobin/drug effects/*metabolism
Nitric Oxide/*adverse effects/therapeutic use
Respiratory Distress Syndrome, Adult/*diagnosis/*drug therapy
Risk Assessment
Pubmed
Web of science
Création de la notice
24/01/2008 17:01
Dernière modification de la notice
20/08/2019 15:09